Back to Results
First PageMeta Content
Nephrology / Medical emergencies / Contrast-induced nephropathy / Radiology / Chronic kidney disease / Radiocontrast agent / Acute kidney injury / Diabetic nephropathy / Creatinine / Medicine / Kidney diseases / Organ failure


Microsoft Word - PLCSF_SCIR.doc
Add to Reading List

Document Date: 2013-08-16 12:06:36

Open Document

File Size: 825,03 KB

Share Result on Facebook

City

Naples / Chicago / /

Company

BACKGROUND PLC Systems Inc. / RenalGuard Favorable AE / Patent Protection PLC / Guidera SA. / Control Group Death Cumulative RenalGuard Group REMEDIAL / New England Journal / CIN Consensus Working Panel / OUTLOOK RenalGuard PLC / RenalGuard Group / Bracco Group / Novadaq Technologies / /

Continent

Europe / /

Country

France / Japan / Brazil / Canada / China / Israel / Germany / Italy / United States / /

Currency

USD / /

/

Event

Patent Issuance / FDA Phase / Dividend Issuance / M&A / Product Issues / Business Partnership / /

Facility

Centro Cardiologico Monzino University / Manchester Royal Infirmary / American College of Cardiology / Tel Aviv Medical Center / Sheeba Hospital / /

IndustryTerm

multi-site / waste product / platform technology / contrast media / imaging / energy / diagnostic imaging equipment / radiographic contrast media / angiographic medical imaging procedures / technology patents / Coronary imaging procedures / impaired gas exchange / higher osmolar media / low-osmolar and isosmolar media / metabolized by-product / sterile solution / fluid replacement device / real-time automated measurement / toxic contrast media / multidisciplinary / radiographic imaging / /

MedicalCondition

chronic renal failure / Unstable Angina/Non-ST-Elevation Myocardial Infarction / severe chronic renal insufficiency / chronic kidney disease / pulmonary edema / severe atherosclerosis / notably chronic renal insufficiency / liver disease / respiratory failure / diabetes / renal failure / acute renal failure / chronic renal insufficiency / ischemic injury / muscle contraction / CIN / end stage renal disease / contrast-induced acute kidney injury / sepsis / irreversible kidney failure / diabetic nephropathy / kidney disease / Acute Kidney Injury / diabetes mellitus / heart attack / dangerous acute kidney injury / /

MedicalTreatment

transmyocardial revascularization / catheterization / kidney transplant / dialysis / fluid therapy / antibiotics / cardiac catheterization / chemotherapy / catheter / hemodialysis / hemofiltration / /

Organization

Sheeba Hospital / Society for Cardiovascular Angiography and Interventions / Tel Aviv Medical Center / the American College / FDA / Ministry of Health / Israel Heart Society / Centro Cardiologico Monzino University in Milan / American Society of Nephrology / Task Force on Practice Guidelines / Administration of N-acetyl-L-cysteine / /

Person

Eyal Nacum / Vaikom Mahadevan / Prince / Fr / Carlo Briguori / Brian Marckx / /

/

Position

worldwide leader / investigator / prevention specialist / Consultant Cardiologist at Manchester Royal Infirmary / PRINCE / cardiologist / long-term driver / Consultant Cardiologist / /

Product

cisplatin / acetylcysteine / sodium bicarbonate / RenalGuard Therapy / amphotericin B / adenosine / furosemide / RenalGuard / Q1 / Kidney Function Particularly Susceptible To CIN Risk / /

ProvinceOrState

Illinois / /

PublishedMedium

the American Journal / New England Journal of Medicine / /

SportsEvent

the Super Bowl / /

Technology

X-ray / Laser System / chemotherapy / dialysis / medical imaging / laser / diagnostic imaging / platform technology / /

SocialTag